Aminoglycoside Antibiotics and Ototoxicity

Introduction to Aminoglycosides

• The American Thorax Society recommends baseline audiometry before starting treatment, regular audiometric testing during treatment, monthly audiometry until treatment with aminoglycoside ceases, and final audiometry review 2 months after the final dose to monitor for ototoxicity 1
• The Centers for Disease Control and Prevention (CDC) suggests adjusting dosing in patients with renal impairment to minimize the risk of ototoxicity 2

Ototoxicity Monitoring and Definition

• Ototoxicity on audiogram is defined as a 20 dB loss from baseline at any one test frequency, or a 10 dB loss at any two adjacent test frequencies, according to the American Thorax Society 1
• Regular monitoring for early symptoms of ototoxicity, such as headache, nausea, vomiting, disequilibrium, tinnitus, and vertigo, is crucial for early detection and intervention 1

Risk Factors and Prevention

• The CDC recommends using the lowest effective dose for the shortest duration possible and considering alternative antibiotics in patients with risk factors for ototoxicity, such as advanced age, impaired renal function, and pre-existing auditory dysfunction 2
• Maintaining adequate hydration during treatment and avoiding concurrent use of other ototoxic drugs when possible can help minimize the risk of ototoxicity 2

Special Considerations

• The American College of Obstetricians and Gynecologists (ACOG) advises avoiding streptomycin during pregnancy, especially in the second and third trimesters, due to the risk of ototoxicity in the fetus 3
• Genetic testing for mitochondrial DNA variants should be considered in patients with a family history of aminoglycoside ototoxicity or maternal history of hearing loss after aminoglycoside use, as recommended by the CDC 2

Alternative Regimens and Protective Measures

• The World Health Organization (WHO) suggests considering alternative regimens that don't include aminoglycosides as first-line treatment for tuberculosis, especially in patients with risk factors for ototoxicity 2
• Implementing rigorous monitoring protocols and considering anti-free radical agents as potential protective measures against ototoxicity can help minimize the risk of permanent hearing loss 1